Form 4 for MRNA Moderna
Accepted 2022-11-18 00:00:00 ET · period of report 2022-11-16 · accession 0001127602-22-026037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-18 | 2022-11-16 | MRNA | Andres Juan | See remarks | S - Sale+OE | $184.25 | -2,000 | 11.8K | -14% | -$368.5K |
| D | 2022-11-18 | 2022-11-16 | MRNA | Andres Juan | See remarks | M - OptEx | $20.93 | +2,000 | 13.8K | +17% | +$41.9K |
| D | 2022-11-18 | 2022-11-16 | MRNA | Andres Juan | See remarks | M - OptEx | $0.00 | -2,000 | 215.0K | -0.9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-16 | S | D | 2,000 | $184.25 | 11,809 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-16 | M | A | 2,000 | $20.93 | 13,809 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2022-11-16 | M | D | 2,000 | $0.00 | 215,025 | D | $20.93 · — to 2029-03-08 | 2,000 Common Stock | (F2) 25% of this option vested and became exercisable on March 8, 2020 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |